Literature DB >> 3134570

Modulation by calcium of the inhibitor activity of naturally occurring urinary inhibitors.

J E Zerwekh1, T I Hwang, J Poindexter, K Hill, G Wendell, C Y Pak.   

Abstract

The possibility that hypercalciuria could cause calcium stone formation through a mechanism other than by increasing urinary saturation of stone-forming calcium salts was explored. The effect of increasing calcium concentration on the inhibitor activity against the spontaneous precipitation of calcium oxalate was examined in whole urine (in the presence of naturally occurring inhibitors) and in synthetic media (with added inhibitors). In 11 patients with calcium nephrolithiasis, the induced hypercalciuria from calcium supplementation (600 mg/day) caused a significant fall in the urinary inhibitory activity against calcium oxalate precipitation, as shown by a decline in the formation product ratio from 12.6 +/- 1.1 SEM to 9.6 +/- 1.4 (P less than 0.005). In order to more fully explore this observation, the effect of increasing calcium concentration on the inhibitory activities of citrate (2 mM), chondroitin sulfate (0.05 mg/liter) and a heterogeneous group of naturally-occurring urinary inhibitors (1.0 mg/liter) against calcium oxalate precipitation was examined in vitro in synthetic solutions. The inhibitory actions of both citrate and chondroitin sulfate were significantly attenuated by increasing calcium concentration from 0.25 mM to 6.0 mM (P less than 0.01). However, raising the calcium concentration in synthetic media containing a mixture of partially purified urinary inhibitors produced a significant rise in the urinary inhibitory activity of this macromolecular mixture (P less than 0.01). We conclude that hypercalciuria can attenuate the inhibitory activities of citrate and chondroitin sulfate against calcium oxalate precipitation while at the same time accentuating the inhibitory activity of naturally-occurring urinary inhibitors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3134570     DOI: 10.1038/ki.1988.100

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

Review 1.  Urine citrate and renal stone disease.

Authors:  H Goldberg; L Grass; R Vogl; A Rapoport; D G Oreopoulos
Journal:  CMAJ       Date:  1989-08-01       Impact factor: 8.262

2.  Crystalluria determined by polarization microscopy. Technique and results in healthy control subjects and patients with idiopathic recurrent calcium urolithiasis classified in accordance with calciuria.

Authors:  U Herrmann; P O Schwille; P Kuch
Journal:  Urol Res       Date:  1991

3.  Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization.

Authors:  F Atmani; B Lacour; T Drüeke; M Daudon
Journal:  Urol Res       Date:  1993-01

4.  The effect of traditional risk factors for stone disease on calcium oxalate crystal adherence in the rat bladder.

Authors:  Charles L Smith; John V St Peter
Journal:  Urol Res       Date:  2007-08-01

5.  Meeting report of the "Symposium on kidney stones and mineral metabolism: calcium kidney stones in 2017".

Authors:  Agnieszka Pozdzik; Naim Maalouf; Emmanuel Letavernier; Isabelle Brocheriou; Jean-Jacques Body; Benjamin Vervaet; Carl Van Haute; Johanna Noels; Romy Gadisseur; Vincent Castiglione; Frédéric Cotton; Giovanni Gambaro; Michel Daudon; Khashayar Sakhaee
Journal:  J Nephrol       Date:  2019-01-24       Impact factor: 3.902

6.  Correlation of serum and ionized calcium in patients with calcium nephrolithiasis.

Authors:  Snjezana Milicevic; Radojka Bijelic; Branislava Jakovljevic; Marija Krivokuca; Vladimir Krivokuca
Journal:  Med Arch       Date:  2014-07-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.